Last modified: 25 Sep 2019 09:58
Study Type | Undergraduate | Level | 1 |
---|---|---|---|
Term | Second Term | Credit Points | Other credits (0 ECTS credits) |
Campus | Aberdeen | Sustained Study | No |
Co-ordinators |
|
The course will comprise a series of lectures and tutorials which will cover the "language" of biobusiness using a number of real case studies from companies in the medical sciences (e.g. What is a company? What is management? How do markets work? Decision making process).
Information on contact teaching time is available from the course guide.
Assessment Type | Summative | Weighting | 50 | |
---|---|---|---|---|
Assessment Weeks | Feedback Weeks | |||
Feedback |
Written feedback provided on continuous assessment elements. |
Word Count |
Knowledge Level | Thinking Skill | Outcome |
---|---|---|
|
Assessment Type | Summative | Weighting | 50 | |
---|---|---|---|---|
Assessment Weeks | Feedback Weeks | |||
Feedback |
Written feedback provided on continuous assessment elements. |
Knowledge Level | Thinking Skill | Outcome |
---|---|---|
|
There are no assessments for this course.
Knowledge Level | Thinking Skill | Outcome |
---|---|---|
Conceptual | Understand | Understanding of the concept and language of business in life sciences. |
Factual | Understand | Understand the initial process of commercialisation of scientific ideas. |
Conceptual | Analyse | Know how business outcomes are influenced by commercial deliverables rather than simply the quality of science. |
Reflection | Evaluate | Have insight into the way risk and cost is managed against the potential revenues that could be generated from a successful drug pipeline. |
We have detected that you are have compatibility mode enabled or are using an old version of Internet Explorer. You either need to switch off compatibility mode for this site or upgrade your browser.